BIMOVIS GmbHIn this interview Dr. Martin Stieler, founder and CEO of BIMOVIS, introduces his company and the importance of structural biology in biotech and pharmaceutical industries, and highlights how BIMOVIS helps unlock the full potential of biomolecular insights to advance drug development and strengthen R&D pipelines.
Tag Archive for: BioRN
BioRNThe subject of impact measurement is of crucial importance for cluster organizations as they continuously aim to enhance their support to their ecosystems with ever more innovative and efficient services. Therefore, the INNAXE’s consortium has recently developed a “Toolbox for Cluster Organisations” allowing them to easily benchmark their regions and monitor the impact of their activities towards their stakeholders.